Coeptis Therapeutics Holdings
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Coeptis Therapeutics Holdings generated cash of -$7,239,514, which is less than the previous year. Cash used in financing activities reached the amount of $4,917,346 last year. Net change in cash is therefore -$2,322,168.

Cash Flow

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW): Cash Flow
2019 -90.06K 0 90.57K
2020 -3.13M -75.75M 2.89M
2021 -4.48M -1.75M 8.21M
2022 -3.87M 0 5.48M
2023 -7.23M 0 4.91M

COEPW Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
3.79M2.17M202.96K440.08K0
Operating activities
Net income
-21.26M-37.57M-13.44M-9.15M-2.23K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
1.00M1.00M447.41K323.42K0
Stock-based compensation expense
477.50K01.89M00
Deferred income tax benefit 477.50K01.89M00
Changes in operating assets and liabilities:
Accounts receivable, net
8.07K-8.07K21.78K-14.90K0
Inventories
00-422.02K732.14K0
Accounts payable
1.32M-35.07K-1.57M1.47M0
Cash generated by operating activities
-7.23M-3.87M-4.48M-3.13M-90.06K
Investing activities
Purchases Of Investments
000-75.75M0
Investments In Property Plant And Equipment
40-1.75M00
Acquisitions Net
00000
Cash generated by investing activities
00-1.75M-75.75M0
Financing activities
Common Stock Issued
4.79M3.27M10.13M1.06M0
Payments for dividends
00000
Repurchases of common stock
00-247.16K00
Repayments of term debt
-575K-2.41M-1.7M-250K0
Cash used in financing activities
4.91M5.48M8.21M2.89M90.57K
Net Change In Cash
-2.32M1.61M1.97M-237.12K505
Cash at end of period
1.46M3.79M2.17M202.96K505
Data sourceData source